NicOx extends ophthalmology agreement with Pfizer
January 9th, 2008
NicOx S.A. has announced it has signed an extension of its March 2006 collaboration agreement, which grants Pfizer Inc the exclusive right to apply its proprietary nitric oxide-donating technology to drug discovery research in the field of ophthalmology.
Original post by Medical News
(click on the author/publication link above to see full post)